Accuracy of radiological staging in identifying high-risk colon cancer patients suitable for neoadjuvant chemotherapy: A multicentre experience

Colorectal Disease

Volumn 14, Issue 4, 2012, Pages 438-444

  Dighe, S ^a   Swift, I ^a   Magill, L ^b   Handley, K ^b   Gray, R ^b   Quirke, P ^c   Morton, D ^d   Seymour, M ^e   Warren, B ^f   Brown, G ^g  

^a MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^e ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^g ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Colon cancer; CT; Neoadjuvant chemotherapy

Indexed keywords

PANITUMUMAB;

ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INFILTRATION; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; COLON CANCER; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOLOGIST; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; NEOADJUVANT THERAPY; NEOPLASM STAGING; PILOT PROJECTS; RISK; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 84863414370     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2011.02638.x     Document Type: Article

References (12)

1. Slater MS, Holland J, Faigel DO, Sheppard BC, Deveney CW. Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 2001; 181: 440-4.
2. Wainberg Z, Hecht JR. A phase III randomized, open-label, controlled trial of chemotherapy and bevacizumab with or without panitumumab in the first-line treatment of patients with metastatic colorectal cancer. Clin colorectal cancer 2006; 5: 363-7.
3. Nelson H, Petrelli N, Carlin A et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001; 93: 583-96.
4. Gray PR, Morton MD, Seymour PM. FOxTROT Fluoropyrimidine, Oxaliplatin & Targeted Receptor pre-Operative Therapy for colon cancer. A randomised trial assessing whether preoperative chemotherapy and/or an anti-EGFR monoclonal antibody improve outcome in high-risk operable colon cancer. Vol. 2007. UK Clinical Research Network, 2007.
5. Merkel S, Wein A, Gunther K, Papadopoulos T, Hohenberger W, Hermanek P. High-risk groups of patients with Stage II colon carcinoma. Cancer 2001; 92: 1435-43.
6. Smith NJ, Bees N, Barbachano Y, Norman AR, Swift RI, Brown G. Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials. Br J Cancer 2007; 96: 1030-6.
7. Dighe S, Blake H, Koh MD et al. Accuracy of multidetector computed tomography in identifying poor prognostic factors in colonic cancer. Br J Surg 2010; 97: 1407-15.
8. Ashraf K, Ashraf O, Haider Z, Rafique Z. Colorectal carcinoma, preoperative evaluation by spiral computed tomography. JPMA 2006; 56: 149-53.
9. Cademartiri F, Luccichenti G, Rossi A, Pavone P. Spiral hydro-CT in the evaluation of colo-sigmoideal cancer. Radiol Med 2002; 104: 295-306.
10. Gomille T, Aleksic M, Ulrich B, Christ F. Significance of CT in the detection of regional lymph node metastases in colorectal carcinoma. Radiologe 1998; 38: 1077-82.
11. Burton S, Brown G, Bees N et al. Accuracy of CT prediction of poor prognostic features in colonic cancer. Br J Radiol 2008; 81: 10-9.
12. Quasar Collaborative Group, Gray R, Barnwell J et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 2007; 370: 2020-9.